Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New ESH/ESC guidelines signal progress in hypertension management.
Hedner T T, Narkiewicz K, Kjeldsen SE, Oparil S; European Society of Hypertension; European Society of Cardiology. Hedner T T, et al. Among authors: kjeldsen se. Blood Press. 2007;16(3):132-4. doi: 10.1080/08037050701550746. Blood Press. 2007. PMID: 17846924 No abstract available.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Dahlöf B, et al. Among authors: kjeldsen se. Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3. Lancet. 2002. PMID: 11937178 Clinical Trial.
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group. Lindholm LH, et al. Among authors: kjeldsen se. J Hypertens. 2002 Sep;20(9):1879-86. doi: 10.1097/00004872-200209000-00035. J Hypertens. 2002. PMID: 12195132 Clinical Trial.
Comparison of the SCOPE and LIFE results.
Kjeldsen SE, Dahlöf B, Devereux RB, Lindholm LH, Nieminen MS, Oparil S, Wedel H; SCOPE Study Group. Kjeldsen SE, et al. J Hypertens. 2003 Sep;21(9):1772-3; author reply 1773. doi: 10.1097/00004872-200309000-00030. J Hypertens. 2003. PMID: 12923412 No abstract available.
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC.
Himmelmann A, Kjeldsen SE, Hedner T. Himmelmann A, et al. Among authors: kjeldsen se. Blood Press. 2003;12(4):196-7. doi: 10.1080/08037050310015854. Blood Press. 2003. PMID: 14596354 No abstract available.
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P. Wachtell K, et al. Among authors: kjeldsen se. Ann Intern Med. 2003 Dec 2;139(11):901-6. doi: 10.7326/0003-4819-139-11-200312020-00008. Ann Intern Med. 2003. PMID: 14644892 Clinical Trial.
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y. Ibsen H, et al. Among authors: kjeldsen se. Hypertension. 2005 Feb;45(2):198-202. doi: 10.1161/01.HYP.0000154082.72286.2a. Epub 2005 Jan 17. Hypertension. 2005. PMID: 15655123 Clinical Trial.
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Reims HM, Oparil S, Kjeldsen SE, Devereux RB, Julius S, Brady WE, Fyhrquist F, Ibsen H, Lindholm LH, Omvik P, Wedel H, Beevers G, de Faire U, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Dahlöf B; LIFE Study Group. Reims HM, et al. Among authors: kjeldsen se. Blood Press. 2004;13(6):376-84. doi: 10.1080/08037050410016483. Blood Press. 2004. PMID: 15771223 Clinical Trial.
693 results